These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31504448)

  • 1. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores.
    Tadros R; Tan HL; ; El Mathari S; Kors JA; Postema PG; Lahrouchi N; Beekman L; Radivojkov-Blagojevic M; Amin AS; Meitinger T; Tanck MW; Wilde AA; Bezzina CR
    Eur Heart J; 2019 Oct; 40(37):3097-3107. PubMed ID: 31504448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel CineECG Derived From Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients With Brugada Syndrome.
    van Dam PM; Locati ET; Ciconte G; Borrelli V; Heilbron F; Santinelli V; Vicedomini G; Monasky MM; Micaglio E; Giannelli L; Mecarocci V; Ćalović Ž; Anastasia L; Pappone C
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008524. PubMed ID: 32755392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting and Recognizing Drug-Induced Type I Brugada Pattern Using ECG-Based Deep Learning.
    Călburean PA; Pannone L; Monaco C; Rocca DD; Sorgente A; Almorad A; Bala G; Aglietti F; Ramak R; Overeinder I; Ströker E; Pappaert G; Măru'teri M; Harpa M; La Meir M; Brugada P; Sieira J; Sarkozy A; Chierchia GB; de Asmundis C
    J Am Heart Assoc; 2024 May; 13(10):e033148. PubMed ID: 38726893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Axis Deviation in Brugada Syndrome: Vectorcardiographic Evaluation during Ajmaline Provocation Testing Reveals Additional Depolarization Abnormalities.
    van der Ree MH; Vendrik J; Kors JA; Amin AS; Wilde AAM; Tan HL; Postema PG
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.
    Conte G; Cattaneo F; de Asmundis C; Berne P; Vicentini A; Namdar M; Scalone A; Klersy C; Caputo ML; Demarchi A; Özkartal T; Salghetti F; Casu G; Passarelli I; Mameli S; Shah D; Burri H; De Ferrari G; Brugada P; Auricchio A
    Europace; 2022 May; 24(5):845-854. PubMed ID: 34499723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST-Elevation Magnitude Correlates With Right Ventricular Outflow Tract Conduction Delay in Type I Brugada ECG.
    Leong KMW; Ng FS; Yao C; Roney C; Taraborrelli P; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Boon Lim P; Harding SE; Peters NS; Kanagaratnam P; Varnava AM
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-Peak to T-End Interval for Prediction of Positive Response to Ajmaline Challenge Test in Suspected Brugada Syndrome Patients.
    Thapanasuta M; Chokesuwattanaskul R; Leelapatana P; Rungpradubvong V; Prechawat S
    Med Sci (Basel); 2022 Dec; 10(4):. PubMed ID: 36548004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of fever-induced Brugada syndrome.
    Mizusawa Y; Morita H; Adler A; Havakuk O; Thollet A; Maury P; Wang DW; Hong K; Gandjbakhch E; Sacher F; Hu D; Amin AS; Lahrouchi N; Tan HL; Antzelevitch C; Probst V; Viskin S; Wilde AA
    Heart Rhythm; 2016 Jul; 13(7):1515-20. PubMed ID: 27033637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate variability and microvolt T wave alternans changes during ajmaline test may predict prognosis in Brugada syndrome.
    Călburean PA; Pannone L; Sorgente A; Gauthey A; Monaco C; Strazdas A; Almorad A; Bisignani A; Bala G; Ramak R; Overeinder I; Ströker E; Pappaert G; Van Dooren S; de Ravel T; La Meir M; Brugada P; Sieira J; Chierchia GB; de Asmundis C
    Clin Auton Res; 2023 Feb; 33(1):51-62. PubMed ID: 36645559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome.
    Batchvarov VN; Govindan M; Camm AJ; Behr ER
    Heart Rhythm; 2009 May; 6(5):625-31. PubMed ID: 19389649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation.
    Postema PG; van Dessel PF; Kors JA; Linnenbank AC; van Herpen G; Ritsema van Eck HJ; van Geloven N; de Bakker JM; Wilde AA; Tan HL
    J Am Coll Cardiol; 2010 Feb; 55(8):789-97. PubMed ID: 20170818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
    Dobbels B; De Cleen D; Ector J
    Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
    Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D
    Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome.
    Cheung CC; Mellor G; Deyell MW; Ensam B; Batchvarov V; Papadakis M; Roberts JD; Leather R; Sanatani S; Healey JS; Chauhan VS; Birnie DH; Champagne J; Angaran P; Klein GJ; Yee R; Simpson CS; Talajic M; Gardner M; Yeung-Lai-Wah JA; Chakrabarti S; Laksman ZW; Sharma S; Behr ER; Krahn AD
    JACC Clin Electrophysiol; 2019 Apr; 5(4):504-512. PubMed ID: 31000106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ajmaline blocks I
    Miller DC; Harmer SC; Poliandri A; Nobles M; Edwards EC; Ware JS; Sharp TV; McKay TR; Dunkel L; Lambiase PD; Tinker A
    Stem Cell Res; 2017 Dec; 25():233-244. PubMed ID: 29172153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.
    Therasse D; Sacher F; Petit B; Babuty D; Mabo P; Martins R; Jesel L; Maury P; Pasquie JL; Mansourati J; Dupuis JM; Kyndt F; Thollet A; Guyomarch B; Barc J; Schott JJ; Le Marec H; Redon R; Probst V; Gourraud JB
    Heart Rhythm; 2017 Oct; 14(10):1442-1448. PubMed ID: 28666944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.